Active	Status	Sponsor type	Region	Phase	Filter
1 Active 3 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
midazolam/ketamine sublingual tablet (MELT-300) / Melt Pharma
NCT06383273: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)	Recruiting	3	528	US	MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet	Melt Pharmaceuticals, MedTrials Incorporated, Evolution Research Group, Catalent, Pharmalex	Cataract	12/24	01/25